AMA submission to Podiatry Board of Australia on Guidelines for Endorsement for Scheduled Medicines
The proposed changes outlined in the Podiatry Board of Australia's Consultation paper on Guidelines for Endorsement for Scheduled Medicines include an expanded List of Scheduled Medicines Approved by the Board (the National Drugs List) for podiatrists to prescribe. The AMA does not support the endorsement of podiatrists for scheduled medicines. We are not convinced that the Australian and New Zealand Podiatry Accreditation Council (ANZPAC) has developed appropriate standards against which to accredit courses on behalf of the Podiatry Board of Australia and is able to undertake accreditation adequately.
The AMA submission to the Podiatry Board of Australia highlights the deficiencies in the Guidelines with respect to course content and accreditation, shared care arrangements and expansion of the National Drugs List.